Rajamäki A
Ann Clin Res. 1981;13 Suppl 33:21-5.
The expenses of blood therapy make up approximately one third of all drug expenses in Finnish hospitals. In large hospitals (university hospitals, central hospitals and large municipal hospitals) more than half of the blood is used for surgical patients. In Turku University Central Hospital surgical blood therapy has been designed and developed with the close cooperation of the haematologists with clinicians. Since 1975 the principles of blood component therapy have been applied in surgery. The share of red cell concentrates has increased to 21.9% of all blood transfusions during the four-year period 1975-1978 but this development was not associated with a concomitant increase in the use of plasma products. The use of fresh blood had decreased markedly to 10.9% of all transfusions in 1978 and the use of platelet concentrates has been restricted to the therapy of thrombocytopenic patients with life threatening bleeding. The present day surgical blood therapy in Turku University Central Hospital can be considered appropriate - even though not yet ideal - from both medical and haematological and economical points of view.
在芬兰医院，血液治疗费用约占所有药品费用的三分之一。在大型医院（大学医院、中心医院和大型市立医院），超过一半的血液用于外科手术患者。在图尔库大学中心医院，血液科医生与临床医生密切合作，设计并开展了外科血液治疗。自1975年以来，血液成分治疗原则已应用于外科手术。在1975年至1978年的四年期间，红细胞浓缩物在所有输血中的占比增至21.9%，但这一变化并未伴随血浆制品使用量的相应增加。1978年，新鲜血液的使用量显著降至所有输血的10.9%，血小板浓缩物的使用仅限于治疗有危及生命出血情况的血小板减少症患者。从医学、血液学和经济学角度来看，图尔库大学中心医院目前的外科血液治疗虽尚未达到理想状态，但可被认为是恰当的。
